Respiration; international review of thoracic diseases, vol.90, no.3, pp.191-8, 2015 (Journal Indexed in SCI Expanded)
Article / Article
Title of Journal :
Respiration; international review of thoracic diseases
Tumor necrosis factor-alpha inhibitors, Tuberculosis, Risk factors, RHEUMATOID-ARTHRITIS, PULMONARY TUBERCULOSIS, FACTOR ANTAGONISTS, FACTOR INHIBITORS, THERAPY, TNF, AGENTS, SURVEILLANCE, INFLIXIMAB, DISEASES
Background: Tumor necrosis factor (TNF)-alpha inhibitors are known to increase the risk of tuberculosis (TB). Objectives: To examine the factors associated with an increased risk of TB in patients receiving anti-TNF-alpha treatment (aTNF-alpha-T).